Galanthamine (CAS 357-70-0) – Cholinesterase Inhibitor API

Galanthamine (CAS 357-70-0) is a potent, naturally derived cholinesterase inhibitor API, extracted and purified from Amaryllidaceae plants with advanced biotechnological processes. Its core mechanism inhibits acetylcholinesterase activity, elevating acetylcholine levels in the brain to enhance synaptic transmission and improve cognitive function. Manufactured under GMP-compliant standards, it guarantees high purity, stable bioactivity and compliance with international pharmaceutical quality specifications.

This premium API serves as a key raw material for pharmaceutical manufacturers developing medications for neurodegenerative disorders. It is widely applied in formulating drugs for mild to moderate Alzheimer’s disease, effectively alleviating cognitive decline symptoms such as memory loss and impaired judgment. With proven clinical safety and targeted efficacy, it addresses the critical demand for reliable cognitive enhancement therapies. For pharmaceutical R&D teams and production enterprises, it provides a trusted solution to advance treatments for neurodegenerative conditions.